Katus; Hugo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Katus; Hugo.The latest application filed is for "abhd5 and partial hdac4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases".

Company Profile

8.18.28

Katus; Hugo - Heidelberg DE
Katus; Hugo - Heddberg DE
Katus; Hugo - Manheim DE
Katus; Hugo - Bammental DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Abhd5 And Partial Hdac4 Fragments And Variants As A Therapeutic Approach For The Treatment Of Cardiovascular Diseases App 20220195398 - Backs; Johannes ; et al.	2022-06-23
ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases Grant 11,312,943 - Backs , et al. April 26, 2	2022-04-26
Compound Decreasing The Concentration Of 2-hydroxy-glutarate App 20220111013 - MULLER; Oliver ; et al.	2022-04-14
Relaxin Receptor 1 For Use In Treatment And Prevention Of Heart Failure App 20220008508 - KATUS; Hugo ; et al.	2022-01-13
Method To Prevent Propagation Of Irregular Electromechanical Waves In The Myocardium By Creating Lines Of Increased Tissue Conductivity App 20210322631 - SCHMIDT; Constanze ; et al.	2021-10-21
Task-1 Inhibitors For Treatment Of Atrial Arrhythmias App 20210308103 - Schmidt; Constanze ; et al.	2021-10-07
Nfat Binding Polynucleotides App 20210070820 - Hecker; Markus ; et al.	2021-03-11
S100 based treatment of cardiac power failure Grant 10,792,329 - Katus , et al. October 6, 2	2020-10-06
Kcnk3-based Gene Therapy Of Cardiac Arrhythmia App 20200308582 - SCHMIDT; Constanze ; et al.	2020-10-01
Complex sets of miRNAs as non-invasive biomarkers for dilated cardiomyopathy Grant 10,718,018 - Keller , et al.	2020-07-21
Wnt Antagonists And Their Use In Methods For Treating Myocardial Infarction App 20190275035 - MEYER; Soren ; et al.	2019-09-12
Means and methods for diagnosing heart failure in a subject Grant 10,393,762 - Fuhrmann , et al. A	2019-08-27
Means And Methods For Differentiating Between Heart Failure And Pulmonary Disease In A Subject App 20190064191 - SCHATZ; Philipp ; et al.	2019-02-28
Abhd5 And Partial Hdac4 Fragments And Variants As A Therapeutic Approach For The Treatment Of Cardiovascular Diseases App 20180258407 - Backs; Johannes ; et al.	2018-09-13
ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases Grant 9,914,912 - Backs , et al. March 13, 2	2018-03-13
Means and Methods for Diagnosing Heart Failure in a Subject App 20170285049 - Schatz; Philipp ; et al.	2017-10-05
Short peptides for enhancing muscle function Grant 9,453,053 - Most , et al. September 27, 2	2016-09-27
Muscle function enhancing peptide Grant 9,428,564 - Most , et al. August 30, 2	2016-08-30
S100 BASED TREATMENT OF CARDIAC POWER FAlLURE App 20160228504 - KATUS; Hugo ; et al.	2016-08-11
Use Of Interleukin 10 Mrna Transfected Macrophages In Anti-inflammatory Therapies App 20160206699 - KAYA; Ziya ; et al.	2016-07-21
Abhd5 And Partial Hdac4 Fragments And Variants As A Therapeutic Approach For The Treatment Of Cardiovascular Diseases App 20160108376 - Backs; Johannes ; et al.	2016-04-21
Use of interleukin 10 mRNA transfected macrophages in anti-inflammatory therapies Grant 9,315,558 - Kaya , et al. April 19, 2	2016-04-19
Means and methods for diagnosing heart failure in a subject Grant 9,285,378 - Fuhrmann , et al. March 15, 2	2016-03-15
Complex Sets Of Mirnas As Non-invasive Biomarkers For Early Diagnosis Of Acute Myocardial Infarction App 20150064704 - Keller; Andreas ; et al.	2015-03-05
System and Computer Program Product for Automatically Distinguishing Atrial Flutter from Atrial Fibrillation App 20140343445 - Scholz; Eberhard ; et al.	2014-11-20
Complex Sets Of Mirnas As Non-invasive Biomarkers For Dilated Cardiomyopathy App 20140194312 - Keller; Andreas ; et al.	2014-07-10
Use Of Interleukin 10 Mrna Transfected Macrophages In Anti-inflammatory Therapies App 20130303596 - Kaya; Ziya ; et al.	2013-11-14
Short Peptides For Enhancing Muscle Function App 20130288971 - Most; Patrick ; et al.	2013-10-31
Modified AAV capsid polypeptides Grant 8,476,418 - Mueller , et al. July 2, 2	2013-07-02
Means and Methods for Diagnosing Heart Failure in a Subject App 20120286157 - Fuhrmann; Jens ; et al.	2012-11-15
Modified Aav Capsid Polypeptides App 20120202732 - Mueller; Oliver ; et al.	2012-08-09
Muscle Function Enhancing Peptide App 20120129758 - Most; Patrick ; et al.	2012-05-24
Osteopontin as Novel Prognostic Biomarker for Heart Failure App 20100267062 - Frey; Norbert ; et al.	2010-10-21
Measuring troponin antibodies to assess cardiovascular risk App 20070172888 - Hallermayer; Klaus ; et al.	2007-07-26
Specific antibodies to troponin T, their production and use in a reagent for the determination of myocardial necrosis Grant 6,376,206 - Katus , et al. April 23, 2	2002-04-23
Monoclonal antibodies to troponin T and their production Grant 6,333,397 - Katus , et al. December 25, 2	2001-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.